Choose which optional cookies and similar storage we may use. Strictly necessary storage is always on, because the site cannot work without it.

Draft: awaiting the Clinical Safety Officer's review before publication

Clinical safety

We manage clinical risk in our products under DCB0129, the NHS standard for manufacturers of health IT. Our Clinical Safety Officer, a practising doctor, leads this work and signs off our clinical safety cases.

Last updated

What DCB0129 and DCB0160 are

DCB0129 and DCB0160 are NHS information standards published under section 250 of the Health and Social Care Act 2012.

DCB0129
For manufacturers of health IT. It covers how the maker identifies, assesses and controls clinical risk in what it builds.
DCB0160
For organisations that deploy and use health IT. It covers the same work from the deploying organisation's side.

Prime Assist has a clinical safety case under DCB0129, signed off by our Clinical Safety Officer.

Draft (K4): Name, professional registration and profile link of the Clinical Safety Officer, with his consent.

Our Clinical Safety Officer

Dr Humzah Jessa is a practising doctor and our Clinical Safety Officer. [TO CONFIRM: professional registration body and number]

Draft (F27): Our clinical risk management process, at a high level: confirm each step.

Our clinical risk management process

  1. Identifying hazards

  2. Assessing risk

  3. Putting controls in place

  4. Keeping the hazard log

  5. The clinical safety case report and sign-off

  6. Monitoring after deployment

  7. Assessing the safety impact of every change

Draft (F27): What we provide to support deploying organisations' DCB0160 work.

Supporting deploying organisations

Organisations that deploy our products, or AI scribes and agents from other suppliers, keep their own clinical safety case under DCB0160. We help them write it and keep it current.

See clinical safety for AI you deploy
Draft (K20): A dedicated route for clinical safety concerns (for example clinicalsafety@gateway-global.co.uk), what to include, and how quickly we respond.

Report a clinical safety concern

[TO CONFIRM: the dedicated route, what to include, and how quickly we respond]

Draft (F27): Medical device status for each product, from the regulatory assessment; supplier-approved wording for third-party components.

Medical device status

[TO CONFIRM from the regulatory assessment]